Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Eli Lilly has announced promising results from a mid-stage clinical trial for a new combination obesity treatment that significantly outperforms…
The desk
Business
42 stories
Judge allows Paramount to close $110 billion takeover of Warner Bros. Discovery
A California judge gave the green light on Wednesday for one of the most ambitious mergers in entertainment history, clearing…
Google announces Gemini 4 Argon AI model, but you can’t use it yet
Google is stepping back into the high stakes race for frontier artificial intelligence with the announcement of Gemini 4 Argon.…
David Ellison Taps Mattel’s Ynon Kreiz to Be Co-CEO of Merged Paramount-Warner Bros.
David Ellison is assembling a powerhouse leadership team as he prepares to launch one of the most ambitious media conglomerates…
Google announces Gemini 4 and says it’s so capable that only ‘trusted cyber defenders’ can have it right now
Google has officially pulled back the curtain on its latest leap in artificial intelligence, unveiling a powerhouse model dubbed Gemini…
Kalshi traders see high odds Anthropic’s IPO is announced this year
Speculative traders on the prediction market Kalshi are increasingly betting that artificial intelligence powerhouse Anthropic will announce its initial public…
Factory CEO just accused his VC board adviser of spying for Cognition
A bitter public feud has erupted between two of the most prominent players in the AI coding space after Matan…
Lilly’s retatrutide GLP-1 delivers average weight loss of 50 pounds
Eli Lilly is pushing the boundaries of weight loss science with its latest experimental medication, retatrutide, which has shown staggering…
Lilly raises diabetes weight-loss bar with amylin-Zepbound combo
Eli Lilly is pushing the boundaries of metabolic medicine with a new combination therapy designed specifically for people battling both…